Um Husserl heterónimo de Pessoa: entre a atitude poética e a atitude fenomenológica
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · 31.05.2024
DOI: 10.26300/9rfa-kv12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna), erschienen am 31.05.2024. Verfasst von Emanuele Mariani.
Abstract (Originalsprache)
Attempts to establish a connection between Fernando Pessoa and Edmund Husserl have not been lacking, interpreting the poetry of one in light of the philosophy of the other, albeit with due caution, given the complete absence of contact between them and the evident diversity of intentions. The results, however, have been mostly negative, and interpreters have primarily chosen to emphasize the limits of Husserl's phenomenology in the face of the “absolute objectivism” of the verses of Alberto Caeiro, the “neo-pagan” poet whom Fernando Pessoa designates as the “master” of his heteronyms. Nevertheless, we believe that another interpretation is possible without denying the insurmountable gap that separates Edmund Husserl and Alberto Caeiro, a heteronym of Fernando Pessoa, due to the principle underlying both the poetic and phenomenological attitude: the “pure vision.”
Schlagwörter
Zitieren
APA
Mariani, E. (2024). Um Husserl heterónimo de Pessoa: entre a atitude poética e a atitude fenomenológica. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). https://doi.org/10.26300/9rfa-kv12
Vancouver
Mariani E. Um Husserl heterónimo de Pessoa: entre a atitude poética e a atitude fenomenológica. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 2024. doi:10.26300/9rfa-kv12
BibTeX
@article{Mariani2024,
author = {Mariani, Emanuele},
title = {Um Husserl heterónimo de Pessoa: entre a atitude poética e a atitude fenomenológica},
journal = {Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)},
year = {2024},
doi = {10.26300/9rfa-kv12}
}
EUVIMED